MESI mTABLET ABI

ABI Measurement with MESI mTABLET | Rapid PAD Diagnosis

The MESI mTABLET ABI is an advanced and fully automated system for measuring the Ankle-Brachial Index (ABI). With high medical accuracy and the exclusive PADsense™ algorithm, it enables rapid, painless detection of Peripheral Arterial Disease (PAD) in under one minute. Its wireless design and full integration with the patient’s digital record make it the ideal choice for vascular screening centers and medical clinics.

Why is ABI Measurement Important?

  • 🦶 Early detection of Peripheral Arterial Disease (PAD): A low ABI can be the first sign of arterial narrowing even in asymptomatic patients.
  • ⚠️ Predicting cardiovascular risk: A reduced ABI is strongly associated with an increased risk of heart attack, stroke, and cardiovascular mortality.
  • 📝 Monitoring treatment efficacy: ABI enables physicians to track the course of disease and evaluate the effectiveness of therapeutic interventions.
  • 🔍 Identifying high-risk patients: ABI should be measured in diabetic patients, smokers, and individuals with hypertension as part of routine vascular assessment.
  • 🧠 A simple tool for comprehensive vascular assessment: ABI is a cost-effective, non-invasive, and widely accepted method for screening and risk stratification.

Key Features of MESI mTABLET ABI

MESI mTABLET ABI represents a new generation of PAD screening tools, combining artificial intelligence, digital automation, and a wireless design to simplify ABI measurement. Unlike traditional methods involving Doppler probes, stethoscopes, or manual inflation, this device performs the entire procedure fully automatically and without user intervention in under one minute.

The device is equipped with the proprietary PADsense™ algorithm, which detects signs of arterial occlusion in real time and eliminates false readings due to improper cuff placement. This allows accurate diagnosis even in patients with diabetes, advanced age, or limited perfusion.

The system is completely modular and portable, with results automatically saved to the patient’s digital file via MESI’s dedicated platform (mRECORDS). No need for printing, manual recording, or transferring data with USB sticks — all information is available instantly and securely online.

In addition, the device features automatic pressure control and adapts to a wide range of patient profiles. It can be used in various clinical settings including clinics, general practices, nursing visits, and even in remote or underserved areas.

For those seeking a fast, easy-to-use, and highly accurate solution that fully integrates with digital records and adheres to the highest clinical standards, MESI mTABLET ABI is the ultimate choice.

🩺 Clinical Benefits of ABI Measurement

  • 🩺 Fast, non-invasive, and cost-effective screening: Ideal for early detection of PAD in high-risk patients without the need for expensive imaging or blood tests.
  • 🔍 Detecting asymptomatic PAD: ABI helps identify patients with PAD before clinical symptoms appear, allowing for timely intervention.
  • ❤️ Cardiovascular risk stratification: A low ABI is a strong predictor of heart attack, stroke, and increased mortality risk.
  • 📊 Monitoring treatment response: ABI provides physicians with a reliable metric to track disease progression and response to therapy.
  • 🧠 Versatile use across care levels: ABI is a key diagnostic tool in cardiology, vascular medicine, and general practice for evidence-based decision-making.

📄 Certifications and International Standards of MESI mTABLET ABI

  • ✔️ CE Certification (Class IIa): Complies with the EU Medical Device Regulation (MDR).
  • 🟥 FDA Clearance (510k K101464): Approved for clinical use in the United States by the FDA.
  • 🌐 ISO 13485 Compliance: Meets global quality standards for medical device manufacturing and performance.
  • 🔐 GDPR Compliance: Ensures full protection of patient data and secure cross-border data exchange under EU law.
  • 🇬🇧 NICE & NHS Support: Recommended in UK NHS screening and care pathways as a validated PAD diagnostic tool.

Clinical Applications of MESI mTABLET ABI

MESI mTABLET ABI is designed for use across a wide range of medical environments — from general practitioner clinics and vascular specialty centers to home visits and public health screening programs. This device helps maximize workflow efficiency and improve the delivery of preventive care.

Thanks to its simplicity, all healthcare staff — even those with limited training — can easily perform ABI measurements. The entire process is fully automated and performed with just a few touchscreen taps, taking less than a minute. The system eliminates human error and saves valuable time during patient screening, making it a highly efficient tool for busy practices.

The portability of MESI mTABLET ABI is another key advantage. With its compact tablet and lightweight cuffs, the system is easy to carry and can be used by nurses, technicians, or physicians during home visits, outreach programs, or community screenings, even in remote locations.

Importantly, MESI mTABLET ABI is one of the few ABI systems in Iran with an official approval for clinical use. This ensures the test is medically recognized and can be reimbursed under defined healthcare billing codes — a critical factor for broader adoption in both public and private sectors.

The device plays a vital role in early detection of Peripheral Arterial Disease (PAD), as well as in therapeutic decision-making for patients with diabetes, the elderly, or those with limited circulation. It also helps avoid unnecessary referrals for Doppler ultrasound or angiography.

In public health programs or primary care, MESI mTABLET ABI stands out for its high accuracy, reliability, and full integration with digital health records (via the mRECORDS platform), eliminating the need for paper printouts or manual data entry.

In short, MESI mTABLET ABI is a clinically proven, cost-effective, and practical tool that fits seamlessly into any healthcare setting — from hospitals to home-based care — and supports international best practices in vascular screening.

Digital Capabilities and Competitive Advantages of MESI mTABLET ABI

MESI mTABLET ABI is a fully digital system that, through its proprietary medical tablet and advanced mRECORDS software, transforms ABI measurement into a fast, smart, and automated experience.

Results are automatically saved and linked to the patient’s digital record. There is no need for printing, human transcription, or sharing via USB — doctors can easily access, print, or send reports with one click.

The system offers full access to medical data across devices — from tablets to mobile phones and desktop PCs. It seamlessly integrates with hospital IT systems (HIS/EHR) and ensures fast, secure, and reliable communication of test results.

Unlike other ABI systems that require manual calculations, specialized skills, or external accessories, MESI mTABLET ABI performs everything automatically — making it not only the most accurate, but also the fastest and most scalable solution in its class.

Frequently Asked Questions about MESI mTABLET ABI

  • 📶 Is the device fully wireless? Yes, all components of the MESI mTABLET ABI connect wirelessly. This enables rapid setup and easy use even in mobile care settings.
  • ✅ Does the device have official certifications? Yes, it is approved for clinical use in the United States and certified under FCC Part 15 and ANSI C63.27. Its FDA clearance number is K201464, and it meets all required safety and performance standards for medical use.
  • 🎯 How is accuracy ensured? The device features the patented “PADsense™” algorithm that enables accurate measurement even in patients with weak arterial flow.
  • 💾 Are the test results saved? Yes, all results are automatically stored and synced with the mRECORDS platform. Reports can be accessed, shared, or archived easily.
  • 🩺 Does the device require calibration? No, the system uses automatic pressure control and does not require periodic manual calibration by the user or service agent.
  • 🏥 In what settings can the device be used? It is suitable for use in hospitals, clinics, home care, mobile screenings, and even remote locations with limited resources.